Chronic kidney disease (CKD) necessitates regular dialysis, a process that often leads to an array of physical and psychological challenges for patients. Fatigue is particularly prevalent among those undergoing these treatments, affecting their quality of life and emotional well-being. Emerging evidence points toward the role of depression as a contributing factor to this fatigue, creating a complex interplay between physical discomfort and psychological health. This study specifically aimed to disentangle these variables, assessing the direct impact of laser acupuncture on fatigue and sleep, independent of any exacerbating factors such as depression and time-varying dialysis symptoms.

The researchers meticulously designed their trial to meet rigorous scientific standards, employing a robust methodology to ensure the validity and reliability of their findings. Participants recruited for the study were carefully screened and randomized to receive either real laser acupuncture or a placebo treatment. The double-blind nature of the trial means that neither the participants nor the treatment administrators knew which intervention was being provided, which further strengthens the credibility of the trial’s outcomes.

The laser acupuncture technique employed in the study uses low-level laser therapy (LLLT), which has been shown to promote tissue healing and reduce inflammation without the invasiveness associated with traditional acupuncture. Participants underwent several sessions of treatment, targeting specific acupuncture points believed to influence fatigue and sleep quality. This non-invasive approach is particularly appealing for dialysis patients, many of whom may be hesitant or unable to engage in more traditional acupuncture techniques.

Initial results from the trial revealed promising outcomes; participants who received laser acupuncture reported significantly lower fatigue levels compared to those who received the placebo treatment. Importantly, these effects were sustained over time, suggesting that laser acupuncture may elicit long-term benefits in combating post-dialysis fatigue.

Sleep quality also improved markedly among participants receiving real laser acupuncture. Improved sleep not only contributes to overall well-being but also plays a critical role in physical recovery and mental health. Given that many dialysis patients struggle with sleep disturbances, the implications of enhanced sleep quality are both profound and far-reaching.

The researchers took great care to analyze and interpret their data methodically. They employed various measurement tools to gauge changes in fatigue levels and sleep quality, including validated scales and questionnaires that have been widely accepted in clinical settings. The integrity of the data and the participants’ subjective experiences led to a comprehensive understanding of how laser acupuncture can directly impact dialysis-related complications.

Moreover, the findings of this research add significant weight to the growing body of evidence supporting complementary therapies in conventional medicine. As the healthcare landscape evolves, there is an increasing need for integrative approaches that encompass both traditional and alternative modalities to treat patients holistically.

Critically, the study also sought to examine the relationship between emotional symptoms, such as depression, and the effectiveness of laser acupuncture. Surprisingly, the results indicated that the benefits of laser acupuncture were achieved regardless of the patient’s baseline levels of depression. This finding highlights the potential of laser acupuncture as a standalone therapeutic intervention, providing hope to patients struggling with various underlying psychological challenges.

As the world continues to navigate the complexities of chronic illness management, the insights garnered from this trial point toward exciting new directions in patient care. While further research is needed to replicate these findings and delve deeper into the mechanisms at play, laser acupuncture presents a compelling option for enhancing the quality of life for dialysis patients.

In a broader context, these results may contribute to reshaping how healthcare providers approach the multifaceted challenges faced by individuals under long-term treatment protocols. This study could inspire more comprehensive modalities of care that address both physical symptoms and psychological well-being, fostering a more holistic approach to health.

As the medical community grapples with the growing demands of chronic disease management, studies such as this one serve as crucial stepping stones toward innovative solutions. As the evidence supporting laser acupuncture continues to mount, it holds the potential to become an integral part of standardized care for patients undergoing dialysis and similar treatments in the future.

Ultimately, this groundbreaking research highlights the need to embrace scientific exploration and validate the efficacy of alternative therapies in conventional medical practice. The promise of laser acupuncture shines brighter than before, paving the way for novel therapeutic avenues that could change the lives of countless individuals affected by chronic illnesses.

The implications of these findings extend beyond the individual patient, as they invite further investigation into the expansive realm of complementary therapies that could revolutionize treatment protocols across various medical disciplines. The journey to understanding and implementing such innovative treatments is only just beginning, and the scientific community remains poised to explore these avenues diligently.

As we continue to observe the interplay between technological advancement and traditional practices in healthcare, we are reminded that innovation in patient care often springs from a synthesis of the old and the new. The findings of Sung, Yeh, Chen, and their colleagues illuminate an inspiring path forward for both researchers and practitioners in the quest for more effective and compassionate health solutions.

In conclusion, as laser acupuncture emerges as a promising adjunctive therapy in the management of post-dialysis fatigue and sleep disturbances, it opens up new possibilities for enhancing patient care. As the upcoming years unfold, ongoing studies and clinical trials will likely further elucidate the role of such therapies in chronic illness management, ultimately enriching the lives of patients and redefining standards of care across the globe.

Subject of Research: Laser acupuncture for post-dialysis fatigue and sleep quality.

Article Title: Laser acupuncture improves post-dialysis fatigue and sleep quality independent of time-varying dialysis and depression symptoms: a double-blind, randomized, placebo-controlled trial.

Article References:

Sung, RY., Yeh, ML., Chen, FP. et al. Laser acupuncture improves post-dialysis fatigue and sleep quality independent of time-varying dialysis and depression symptoms: a double-blind, randomized, placebo-controlled trial.
BMC Complement Med Ther (2025). https://doi.org/10.1186/s12906-025-05203-3

Image Credits: AI Generated

DOI:

Keywords: Laser acupuncture, post-dialysis fatigue, sleep quality, chronic kidney disease, alternative therapy.

Weighted blankets, designed to apply gentle pressure similar to a hug, have gained popularity as a non-pharmaceutical option for those struggling with sleep disturbances. The researchers conducted a controlled study to assess the impact of this innovative tool on children diagnosed with ADHD. The use of weighted blankets is particularly intriguing given their ability to induce a state of calmness and improve sleep quality, which is essential for overall well-being.

The structure of the study was meticulously crafted, with a focus on comparing health-related factors between children with ADHD who experienced sleep problems and those who did not. By isolating these variables, the researchers aimed to unveil the underlying mechanisms at play when utilizing weighted blankets. It was imperative to ensure that all participants were in similar environments and conditions to derive accurate conclusions.

In the initial phases of the study, the participants were first assessed to determine their baseline sleep patterns and ADHD symptoms. Standard questionnaires and sleep diaries were utilized to gather data regarding sleep duration, sleep onset latency, and overall sleep quality. The meticulous nature of this data collection laid the groundwork for an informed analysis of the subsequent interventions.

Once the baseline data had been collected, the families of children experiencing sleep issues were then provided with weighted blankets. Over a six-week period, parents reported back on their children’s responses to the blankets, noting changes in sleep duration, sleeping patterns, and behavioral improvements. This longitudinal approach enabled researchers to observe the long-term implications of the weighted blankets on sleep and ADHD symptoms.

Preliminary findings suggested that children who used weighted blankets reported significantly fewer sleep disturbances when compared to those who did not receive the intervention. The effects on behavior were equally notable; parents observed reductions in hyperactivity and improvements in focus during daily activities. These shifts underscore the interplay between sleep and ADHD symptoms, emphasizing the importance of addressing sleep issues early on in treatment plans.

Furthermore, the study takes into account the neurobiological underpinnings of the issues at hand. Sleep plays a crucial role in cognitive function, emotional regulation, and even physical health. Children with ADHD, who often struggle with executive function, may find that sleep deprivation exacerbates their difficulties. Consequently, enhancing sleep quality via weighted blankets, which elicit a calming effect, may serve as an effective strategy to mitigate ADHD symptoms.

As the research progresses, the findings hold significant implications for treatment approaches in pediatric mental health. Weighted blankets could represent an accessible, cost-effective intervention for families seeking non-invasive methods to improve their children’s sleep quality. The gravitational pressure provided by weighted blankets has the potential not only to improve sleep quality but also to enhance overall psychological well-being in children with ADHD.

Moreover, this study contributes to the body of literature advocating for a holistic approach to treating ADHD. With a growing awareness of the intricate relationship between various health factors, there is a shift toward considering comprehensive treatment plans that address physiological, psychological, and environmental aspects. The integration of weighted blankets into such plans is a testament to the evolving perspectives on ADHD management.

Importantly, these findings also elevate discussions surrounding the stigma often associated with ADHD and sleep disorders. By investigating non-pharmacological interventions, the research provides a platform for recognizing behavioral and environmental adjustments that can significantly improve the quality of life for affected individuals. In a sense, it demystifies ADHD and puts forth a narrative of hope and possibility.

The research team is hopeful that their findings will lead to further studies examining the long-term effects of weighted blankets on ADHD, sleep disorders, and overall health outcomes. There remains a critical need for expansive research to further validate these initial promising results while bridging the gap between pediatric sleep medicine and behavioral health.

Ultimately, this study champions the potential of innovative and non-invasive strategies for enhancing the lives of children with ADHD. With attention to sleep’s significant role in health and behavior, the understanding of ADHD continues to deepen, promising a future where children can thrive in a supportive and understanding environment. The implications for families struggling with sleep and ADHD issues are profound, emphasizing a clear path toward improved mental health and well-being through community awareness and scientific inquiry.

Subject of Research: The impact of weighted blankets on children with ADHD and sleep problems.

Article Title: Comparisons of health-related factors in children with attention-deficit/hyperactivity disorder with and without sleep problems following a weighted blanket sleep intervention.

Article References: Malmborg, J.S., Tuvesson, J., Larsson, I. et al. Comparisons of health-related factors in children with attention-deficit/hyperactivity disorder with and without sleep problems following a weighted blanket sleep intervention. BMC Pediatr 25, 678 (2025). https://doi.org/10.1186/s12887-025-06051-3

Image Credits: AI Generated

DOI:

Keywords: ADHD, Weighted Blankets, Sleep Problems, Pediatric Health, Behavioral Interventions

Insomnia and sleep disturbances affect roughly one-third of the global population at some point in their lives, with approximately 10 percent meeting the clinical criteria for insomnia disorder—a condition characterized by chronic difficulty in initiating or maintaining sleep that significantly impairs daytime functioning. Conventional pharmacological treatments, such as benzodiazepines or non-benzodiazepine hypnotics, often pose risks including tolerance, dependence, and adverse side effects, leaving a critical need for safer and more effective therapies.

Exploring cannabis-based medicinal products as an alternative treatment, the researchers analyzed patient-reported outcomes, focusing on subjective sleep quality, levels of anxiety and depression, and overall quality of life. These metrics provide a comprehensive understanding of how insomnia and associated symptoms respond to cannabis-based interventions over a substantial timeframe. The observational design of the study offers real-world evidence while acknowledging the necessity for future randomized controlled trials to confirm causality and further validate efficacy.

Patients enrolled in the study demonstrated significant, sustained improvements in self-reported sleep quality throughout the duration of the study. Notably, these benefits persisted for up to 18 months, suggesting that cannabis-based products may mitigate the issues of tolerance and diminishing effects observed with many traditional hypnotics. This sustained improvement points to a promising role for cannabinoids in sleep regulation pathways, potentially involving interactions with the endocannabinoid system, which is known to influence circadian rhythms and sleep architecture.

In addition to enhancements in sleep, the study participants showed marked reductions in anxiety and depression symptoms, conditions frequently comorbid with insomnia that exacerbate sleep difficulties. Such improvements are particularly relevant because psychoactive cannabinoids like THC and non-intoxicating compounds such as CBD have demonstrated anxiolytic and mood-stabilizing properties in other clinical contexts, implying a multifaceted therapeutic profile for medical cannabis in neuropsychiatric symptom management.

Pain—a notable contributor to sleep disruption—also lessened significantly among the study cohort. Chronic pain conditions often interfere with the onset and maintenance of restful sleep, and cannabinoids have been widely studied for their analgesic properties. The dual action on pain and sleep disturbances might explain the observed comprehensive improvements and highlight the potential for cannabis formulations tailored to complex symptom clusters.

Side effects associated with cannabis-based medicinal treatment were reported by approximately nine percent of patients, including fatigue, insomnia paradoxically, and dry mouth. Importantly, none were life-threatening or severe enough to warrant discontinuation in most cases. These findings underscore that while not without risk, the safety profile of cannabis-based products may compare favorably to that of conventional hypnotics, which often carry risks of dependence, cognitive impairment, and other adverse outcomes.

Dr. Simon Erridge, Research Director at Curaleaf Clinic and co-author of the study, underscored the significance of these findings in the clinical management of insomnia. He emphasized the importance of monitoring potential tolerance development over time and tailoring treatments on an individual basis to maximize efficacy while mitigating risks. The practical implications for clinicians include the possibility of integrating cannabis-based products as adjunctive or second-line therapy, particularly in patients unresponsive to or intolerant of standard pharmacological options.

The observational nature of this research is both a strength and a limitation. While allowing a realistic picture of patient experiences over an extended period, it inherently cannot establish cause-effect relationships. Confounding variables such as lifestyle changes, placebo effects, and the variability in product formulations and dosages require careful consideration. Nevertheless, the study’s real-world evidence broadens our understanding of medical cannabis’s therapeutic potential, encouraging further rigorously controlled investigations.

From a neurobiological perspective, it has been hypothesized that cannabinoids modulate sleep through their action on CB1 receptors in the central nervous system. These receptors influence neurotransmitters implicated in sleep cycles, such as GABA and glutamate. Moreover, the balance of THC and CBD in medicinal formulations could account for differential effects on sleep latency and maintenance, where THC’s sedative properties complement CBD’s anxiolytic and anti-inflammatory effects, possibly improving sleep architecture and subjective restfulness.

The complex interplay between insomnia, mental health, and pain highlights the multifactorial nature of chronic sleep disorders. Cannabis-based treatments potentially target these overlapping symptoms simultaneously, addressing the limitations of mono-target pharmacotherapeutics. Additionally, favorable patient-reported outcomes may promote adherence, an essential factor often overlooked in clinical trials but critical for real-world success.

As the legal and regulatory landscapes evolve, so too does the urgency to clarify the clinical role of cannabis-based medicinal products. The study’s findings contribute to a growing body of literature advocating for the thoughtful incorporation of these treatments into personalized medicine strategies. However, regulatory agencies and healthcare professionals must weigh these benefits against potential risks, emphasizing careful screening, dosing protocols, and longitudinal follow-up.

In conclusion, this pioneering investigation offers encouraging evidence that cannabis-based medical products can provide meaningful and sustained improvements in sleep quality and associated symptoms over an extended period. While not a panacea, these findings illuminate a promising avenue for patients grappling with the often intractable challenge of insomnia. The research paves the way for future randomized trials that will be critical in defining standardized treatment guidelines and integrating cannabinoid therapies into mainstream clinical practice.

For full access to the study and detailed data, the article appears freely available in PLOS Mental Health, reinforcing the commitment to open science and the dissemination of knowledge that may benefit insomnia patients worldwide.

Subject of Research: People

Article Title: UK Medical Cannabis Registry: A clinical outcomes analysis for insomnia

News Publication Date: 27-Aug-2025

Web References: https://doi.org/10.1371/journal.pmen.0000390

References:
Aggarwal A, Erridge S, Cowley I, Evans L, Varadpande M, Clarke E, et al. (2025) UK Medical Cannabis Registry: A clinical outcomes analysis for insomnia. PLOS Ment Health 2(8): e0000390. https://doi.org/10.1371/journal.pmen.0000390

Image Credits: Photo by Jeff W on Unsplash (free to use under the Unsplash License)

A comprehensive systematic review published in the reputable journal PLOS One provides illuminating insights into the safety and efficacy of mouth taping, particularly for those experiencing sleep-disordered breathing and obstructive sleep apnea (OSA). A collaborative effort between Lawson Research Institute, London Health Sciences Centre Research Institute (LHSCRI), and Western University’s Schulich School of Medicine & Dentistry, the study delved into 86 previously published research papers. It further conducted an in-depth evaluation of 10 key studies encompassing data from 213 patients, revealing alarming results that challenge the purported health benefits touted on social media.

Mouth breathing during sleep is a well-recognized symptom of several health conditions, including nasal obstructions and OSA. However, forcibly preventing this natural compensatory mechanism by taping the lips can exacerbate respiratory distress. The review highlights that individuals who tape their mouths shut risk obstructing normal airflow, especially if nasal passages become blocked at night. Such blockage can lead to increased respiratory effort, oxygen deprivation, and in extreme cases, suffocation. This is particularly concerning for patients unaware that they suffer from sleep apnea, a condition responsible for intermittent airway collapse causing disrupted breathing and poor sleep quality.

From a physiological perspective, nasal breathing plays a critical role in air filtration, humidification, and nitric oxide production, which assists in vascular regulation and immune defenses. While shifting to nasal breathing might offer benefits under certain circumstances, rigidly enforcing it through mouth taping without medical evaluation dismisses the body’s intricate respiratory reflexes. The review emphasizes the absence of strong, consensual scientific evidence supporting mouth taping’s health advantages, contradicting claims of improved sleep architecture, dental health, or skin rejuvenation circulating online.

Dr. Brian Rotenberg, an otolaryngologist and sleep surgeon deeply involved in the research, expressed significant concern about the trend’s viral popularity. He underscored that social media often amplifies unverified health advice without adequately addressing potential dangers or contraindications. “What initially seemed like a trending health hack turned out to have substantial risks, especially for sufferers of sleep apnea who might not even be aware of their condition,” Dr. Rotenberg stated. This lack of awareness could lead to worsened symptoms and increased susceptibility to serious cardiovascular complications such as hypertension and heart disease, both closely linked to untreated sleep-disordered breathing.

The study’s findings also draw attention to the broader issue of how pseudoscience propagates in the digital age. With misinformation spreading rapidly, consumers often lack access to reliable, evidence-based guidance. Jess Rhee, a medical resident associated with the project, stresses the importance of grounding health decisions in rigorous scientific research. She notes that while the allure of easy fixes is understandable, reliance on anecdotal social media endorsements can impede diagnosis and treatment of underlying medical conditions. Rhee’s perspective highlights the pressing need for public health education initiatives that counteract misguided wellness fads and promote professional consultation.

Methodologically, the researchers utilized content analysis to systematically evaluate a spectrum of clinical trials, observational studies, and case series related to mouth taping and breathing disorders. The heterogeneity of study designs and patient populations posed challenges but also underscored the lack of high-quality, randomized controlled trials validating the practice. This deficiency further supports caution against adopting mouth taping as a generalized intervention without personalized medical oversight.

The paper’s implications extend beyond individual behavior to healthcare policy and clinical practice. Sleep specialists and primary care providers may encounter patients attempting mouth taping without disclosing it, complicating diagnostic assessments. Recognizing these emerging trends enables clinicians to proactively inquire about such practices and educate patients on safer alternatives. Moreover, the research invites further investigation into tailored therapies that support nasal breathing without risking airway compromise.

From a translational science standpoint, this study exemplifies the critical intersection of laboratory research, clinical evidence, and public health communication. It illustrates the responsibility of research institutions to monitor emerging wellness trends and generate data that safeguard populations from inadvertent harm. The collaboration among Lawson Research Institute, LHSCRI, and Western University demonstrates the power of academic partnerships in addressing contemporary health challenges exacerbated by viral misinformation.

In conclusion, while the concept of improving breathing patterns during sleep remains valid, mouth taping as a self-administered practice is fraught with risks that overshadow purported benefits. Individuals experiencing sleep disturbances or suspecting obstructive breathing should consult healthcare professionals for appropriate diagnostics and evidence-based treatments. Until more definitive research emerges, mouth taping should be approached with caution, and the public must be alerted to the potential perils associated with this trendy but potentially hazardous sleep hack.

Subject of Research: People

Article Title: Breaking social media fads and uncovering the safety and efficacy of mouth taping in patients with mouth breathing, sleep disordered breathing, or obstructive sleep apnea: A systematic review

News Publication Date: 21-May-2025

Web References:

• London Health Sciences Centre Research Institute (LHSCRI)
• Lawson Research Institute
• Western University

Keywords: Sleep apnea, sleep disorders, mouth taping, obstructive sleep apnea, respiratory health, nasal breathing, sleep-disordered breathing, social media health trends

Recent research by a team at the Regenstrief Institute has uncovered an innovative approach to managing this cancer-related fatigue through a therapeutic method known as acceptance and commitment therapy (ACT). Unlike conventional strategies that focus on symptom alleviation, ACT embraces a more holistic perspective, aiming to enhance psychological flexibility. This approach integrates elements of mindfulness and behavioral change, fostering a deeper, more compassionate acceptance of one’s current state, whether it pertains to physical sensations or emotional experiences. The goal is to enable patients to live more fully despite their ongoing struggles with the disease.

A distinctive aspect of this study was the implementation of telephone-delivered ACT sessions, which showcased both feasibility and effectiveness. During the trial, 250 participants diagnosed with metastatic breast cancer were randomly assigned to either six weekly phone sessions of ACT or a standard education and support program. The results indicated that participants who engaged in the ACT sessions reported a notable decrease in the interference of fatigue with their daily functioning, as well as improvements in sleep quality—an often-neglected yet critical factor in overall well-being.

These findings underscore the profound connection between sleep and fatigue, particularly among cancer patients. Dr. Shelley Johns, a research scientist and lead investigator on the study, noted that participants frequently observed enhancements in their sleep quality. This was attributed to mindfulness practices incorporated into their nightly routines, which not only facilitated better sleep but also nurtured a sense of tranquility. Sleep deprivation can exacerbate feelings of fatigue, creating a vicious cycle that negatively impacts both mental and physical health. Thus, ACT’s focus on cultivating mindfulness appears to provide dual benefits by improving sleep and mitigating fatigue.

Mindfulness, as a core component of ACT, emphasizes living in the moment, which includes acknowledging current physical sensations and emotional states without harsh judgment. By adopting an attitude of acceptance towards their experiences, patients may avoid detrimental thought patterns such as rumination or catastrophizing about their condition. This shift in perspective can empower them to make informed choices that positively influence their quality of life, redirecting their focus from mere survival to meaningful living.

The clinical implications of this study are significant, providing a promising pathway for enhancing the quality of life for individuals battling metastatic breast cancer. As noted by Dr. Catherine Mosher, the first author of the study, effective pharmacological options for addressing fatigue in advanced cancer remain limited. Therefore, behavioral interventions like ACT represent vital alternatives to the current standard of care. The feasibility of training clinicians across various disciplines in ACT further enhances its potential integration into routine clinical practice.

Moreover, the success of this telephone-delivered intervention raises the important possibility of adapting ACT for diverse populations afflicted by cancer. Future research endeavors aim to test the effectiveness of this approach in culturally varied groups to ensure that it resonates with different communities facing unique challenges and experiences. Accessibility in cancer care must be a priority, as disparities in treatment can adversely affect outcomes for marginalized populations.

The impact of a cancer diagnosis extends far beyond the biological aspects of the disease; it infiltrates emotional health, relationships, and daily life. Research shows that emotional distress is a common occurrence among cancer survivors, contributing to fatigue and compromise in their quality of life. This study introduces a new frontier in cancer care by providing an evidence-based, innovative approach that could revolutionize patient support strategies. The ability to engage with mental health interventions through virtual platforms places this therapy in line with modern accessibility trends in healthcare.

As the dialogue surrounding cancer survivorship evolves, the integration of psychological therapies like ACT into the overall treatment framework represents a paradigm shift. Patients are increasingly being recognized as complex individuals whose needs extend beyond physical health. A comprehensive approach that embraces mental well-being alongside medical interventions promises to yield a more robust foundation for healing and living well post-diagnosis.

In summary, the adoption of ACT as a viable option for managing fatigue among metastatic breast cancer patients opens new avenues for patient care. While traditional treatment modalities remain vital, incorporating psychological strategies empowers patients to reclaim agency in their health journey. As healthcare continues to innovate, the integration of behavioral therapies into standard treatment protocols stands as a compelling model for enhancing patient outcomes, ultimately leading to a future where holistic care becomes the norm rather than the exception.

The study titled “Randomized Controlled Trial of Acceptance and Commitment Therapy for Fatigue Interference With Functioning in Metastatic Breast Cancer,” published in the esteemed Journal of Clinical Oncology, represents a significant contribution to ongoing research in this field. As the authors underscore, the integration of ACT in clinical practice could revolutionize how healthcare providers address fatigue—a pervasive and debilitating companion to cancer treatment—thereby crafting pathways for more effective, compassionate care.

With the evidence firmly laid before the medical community, next steps involve broader dissemination of these findings and further exploration into how best to implement ACT across varying demographics. This ongoing commitment to research and patient care exemplifies the potential for psychological therapies to collaborate seamlessly with medical treatments, thus fostering a better quality of life for those impacted by cancer.

In conclusion, the marriage of behavioral health interventions and oncological care represents a crucial step forward in the quest for holistic cancer treatment. As patients, practitioners, and researchers engage in this dialogue, the ultimate goal remains clear: to enhance life quality and living experiences for individuals confronting one of life’s most formidable challenges, cancer.

Subject of Research: Acceptance and Commitment Therapy for Metastatic Breast Cancer Fatigue
Article Title: Randomized Controlled Trial of Acceptance and Commitment Therapy for Fatigue Interference With Functioning in Metastatic Breast Cancer
News Publication Date: 25-Oct-2024
Web References: Journal of Clinical Oncology
References:
Image Credits:
Keywords: Acceptance and Commitment Therapy, Metastatic Breast Cancer, Cancer Fatigue, Quality of Life, Mindfulness, Behavioral Health, Clinical Research, Psychological Flexibility